ARA-290 (16mg)
$88.00
ARA-290 (16mg) is offered by Biotech Peptides for laboratory and analytical research. Also called cibinetide, ARA-290 is a synthetic 11-residue peptide derived from the beta-helix domain of erythropoietin, studied in relation to innate repair receptor signaling and inflammatory pathways. 1181
-
Product: ARA-290
-
Alternative name: Cibinetide
-
Listed quantity: 16 mg
-
Reference molecular formula: C₅₁H₅₄N₁₆O₂₁
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
ARA-290 (16mg) for Laboratory Research
ARA-290 (16mg) is offered by Biotech Peptides for laboratories investigating innate repair receptor signaling, inflammatory pathways, and neuropathic pain research. ARA-290 is a synthetic 11-residue peptide derived from the beta-helix domain of erythropoietin. 1181
For laboratories looking to buy ARA-290, this listing identifies a 16 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.
Explore our research peptides for sale to review other laboratory-use listings.
ARA-290 Product Information
| Property | Listing information |
|---|---|
| Product name | ARA-290 |
| Alternative name | Cibinetide |
| Listed quantity | 16 mg |
| Intended application | Laboratory and analytical research |
| Documentation inquiries | Include the product name and batch or lot number, where available |
The 16 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.
ARA-290 Reference Molecular Characteristics
The following characteristics describe the ARA-290 reference structure. They are not analytical confirmation of an individual commercial batch.
| Reference characteristic | Information |
|---|---|
| Peptide length | 11 residues |
| Reference sequence | Pyr-Glu-Glu-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH |
| Molecular formula | C₅₁H₅₄N₁₆O₂₁ |
| Approximate molecular weight | 1257.3 g/mol |
| CAS number | 1208243-50-8 |
| Chemical class | Synthetic peptide derived from erythropoietin |
The sequence, molecular formula, molecular weight, and CAS number are documented in the ARA-290 research summary and in the ARA-290 research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1182
ARA-290 and Innate Repair Receptor Research
A review of ARA-290 and innate repair receptor signaling describes ARA-290 as a selective IRR agonist that is an 11-amino acid peptide initially tested in animal models of neuropathy. The same review notes that ARA-290 is a molecule that has been evaluated extensively in neuropathic pain. 1183
A separate review of ARA-290 and innate repair receptor signaling describes ARA-290 as a peptide derived from the tertiary structure of erythropoietin that produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response. The same review notes that ARA-290 produces its effects via activation of the beta-common-receptor. 1185
Read the review of ARA-290 and innate repair receptor signaling for the molecular mechanisms and evidence limitations.
Neuropathic Pain Research
A study of ARA-290 and neuropathic pain reported that ARA-290 produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response. The investigators reported that ARA-290 produces its effects via activation of the beta-common-receptor. 1185
A separate study of ARA-290 and neuropathic pain reported that ARA-290 is a molecule that has been evaluated extensively in neuropathic pain. The investigators reported that ARA-290 is a molecule that has been evaluated extensively in neuropathic pain. 1183
These findings apply to specific animal models and exposure protocols. They do not establish that a commercial ARA-290 batch reduces neuropathic pain or produces a cosmetic effect in humans. 1183
Research Limitations
Published ARA-290 research examines receptor signaling, cell-based assays, and animal models. It does not establish that ARA-290 treats neuropathy, inflammation, diabetes, or any other condition. 1181
Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.
Documentation and Batch Verification
Before selecting ARA-290 (16mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:
-
Product name and batch or lot identifier.
-
Manufacturer specifications and chemical form.
-
Salt state and counterion information, where applicable.
-
Identity-testing methods and reported results.
-
Purity-testing methods and supporting analytical data.
-
Quantity or peptide-content measurements, where required.
-
Product-specific storage and handling instructions.
Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.
For inquiries, provide “ARA-290 (16mg),” the batch number where available, and the specific information your laboratory requires.
Storage and Handling
Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.
Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.
Frequently Asked Questions About ARA-290 (16mg)
What is ARA-290?
ARA-290 is a synthetic 11-residue peptide derived from the beta-helix domain of erythropoietin. 1181
Is ARA-290 the same as cibinetide?
Yes. ARA-290 and cibinetide refer to the same molecule. 1181
Does ARA-290 reduce neuropathic pain?
A study of ARA-290 and neuropathic pain reported that ARA-290 produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response. This does not establish that a commercial ARA-290 batch reduces neuropathic pain in humans. 1183
What does the 16mg designation mean?
It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.
Does published research verify this product?
No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.
Where can I find delivery information?
Review our shipping information for current order-processing and delivery terms.
Research Use Only
ARA-290 (16mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.
Review our Research-Use-Only Policy before ordering.
| Brand | Biotech Peptides |
|---|
Related products
ACE-031 (1mg)
ACE-031 (1mg) is offered by Biotech Peptides for laboratory and analytical research. ACE-031 is a soluble fusion protein comprising the extracellular domain of activin receptor type IIB fused to the Fc portion of human IgG1, studied in relation to myostatin signaling and muscle-mass regulation. 1198
-
Product: ACE-031
-
Alternative name: Ramatercept
-
Listed quantity: 1 mg
-
Reference molecular weight: 77.24 kDa
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Lipopeptide (Biopeptide EL) (200mg)
- Product name: Lipopeptide (Biopeptide EL)
- Listed quantity: 200mg
- Chemical name: Palmitoyl Hexapeptide-12
- Peptide sequence: Val-Gly-Val-Ala-Pro-Gly (VGVAPG)
- Molecular formula: C₃₈H₆₈N₆O₈
- Molecular weight: Approximately 737.0 g/mol
- CAS number: 171263-26-6
Melanotan 1 (10mg)
Melanotan 1 (10mg) is offered by Biotech Peptides for laboratory and analytical research. Also called afamelanotide, this synthetic 13-residue analogue of alpha-melanocyte-stimulating hormone has been studied in relation to melanocortin receptor signaling and melanin production.pmc.ncbi.nlm.nih+1
-
Product: Melanotan 1
-
Alternative name: Afamelanotide
-
Listed quantity: 10 mg
-
Reference molecular formula: C₇₈H₁₁₁N₂₁O₁₉
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Pal-AHK (200mg) | Biotech Peptides
Pal-AHK (200mg) is listed as a palmitoylated AHK tripeptide for laboratory and analytical research. The supplied product description identifies the proposed structure as palmitoyl-Ala-His-Lys, combining an alanine-histidine-lysine peptide sequence with an N-terminal palmitoyl group.
Proposed reference characteristics (subject to manufacturer confirmation):- Listed quantity: 200mg
- Proposed peptide sequence: Ala-His-Lys (AHK)
- Proposed modification: N-terminal palmitoyl group
- Proposed molecular formula: C₃₁H₅₆N₆O₅
- Proposed molecular weight: Approximately 592.8 g/mol
Pal-GHK (Palmitoyl Tripeptide-1) (200mg) | Biotech Peptides
Pal-GHK (Palmitoyl Tripeptide-1) (200mg) is a synthetic, lipid-modified tripeptide listed for laboratory and analytical research involving peptide chemistry and skin-related research models.
Also known as Palmitoyl-Gly-His-Lys, Pal-GHK consists of a palmitoyl group attached to the N-terminus of the GHK tripeptide sequence. It has been investigated in research involving extracellular matrix components and topical cosmetic formulations. Reference molecular information:- Listed quantity: 200mg
- Peptide sequence: Gly-His-Lys (GHK)
- N-terminal modification: Palmitoyl group
- Molecular formula: C₃₀H₅₄N₆O₅
- Molecular weight: 578.8 g/mol
- CAS number: 147732-56-7
- Common name: Palmitoyl Tripeptide-1
PT-141 (Bremelanotide) (10mg)
PT-141 (Bremelanotide) (10mg) is offered by Biotech Peptides for laboratory and analytical research. Also called bremelanotide, this synthetic cyclic heptapeptide is a melanocortin receptor agonist studied in relation to MC1R, MC3R, and MC4R signaling.accessdata.fda+2
-
Product: PT-141 (Bremelanotide)
-
Alternative name: Bremelanotide
-
Listed quantity: 10 mg
-
Reference molecular formula: C₅₀H₆₈N₁₄O₁₀
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
